UCB is committed to doing business with integrity
2024 Annual Report
The 2024 Integrated Annual Report provides an overview of how UCB creates value for those we care for – people living with severe diseases, employees, communities, the planet, and our shareholders – now and into the future. Access this report to read more detail about UCB’s performance in 2024.
Ethics & Business Integrity
At UCB Australia, we are committed to ethical business practices. We believe what we do is just as important as how we do it and strive to do business the right way and ethically each day. Learn more about how we create a culture of ethics and compliance, with drive to act with integrity.
Medicines Australia Collaboration
UCB Australia, in collaboration with Medicines Australia, is proud to support the Stronger PBS Campaign and National Strategic Action Plan for Rare Disease to help improve access to medicines for all Australians, including those living with rare diseases. Learn more about these important initiatives.
Medicines Australia Reporting
As a member of Medicines Australia, UCB Australia is committed to transparency in our interactions with healthcare professionals and patient organisations. Learn more about how we provide reports to Medicines Australia.
Patient Safety & Product Quality
In everything we do at UCB Australia, we focus on the person, not just the condition. Through close partnerships with patient communities, we uphold the highest quality standards in every product. Learn more about our commitment to patient safety and product quality.
AU-OT-2400024. June 2025.